Description of the use of multicriteria to support pricing and reimbursement decisions by European health technology assessment bodies

• Egile Nagusiak: David Elvira (Egilea), Mercè Obach (Egilea), Caridad Pontes (Egilea)
• Formatua: Liburua
• Argitaratua: BMC, 2021-08-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Abstract Background Heterogeneity in drug access throughout Europe may be influenced by differences in drug-assessment strategies. The EUnetHTA's assessment core model (EUnetHTA-core) and the EVIDEM's multicriteria framework are reference methodologies in this context, the latter including...